David Medical(300314)2025-01-23 08:42Financial Performance - The company's net profit attributable to shareholders is expected to be between 57 million and 77 million CNY, representing a decline of 47.84% to 61.38% compared to the same period last year[2] - The net profit after deducting non-recurring gains and losses is projected to be between 53 million and 73 million CNY, reflecting a decrease of 43.20% to 58.76% year-over-year[2] - The overall sales revenue and profit have shown a certain degree of decline due to industry policies and market demand factors[4] Investment and Income - Investment income accounted for using the equity method has decreased compared to the previous year[4] - Exchange gains have reduced due to fluctuations in the RMB to USD exchange rate[4] Forecast and Auditing - The performance forecast data is based on preliminary calculations by the company's finance department and has not been audited by the accounting firm[5]